Knupp Catherine
Management
Zoetis
Austria
Biography
Prior to joining Pfizer Animal Health, Dr. Knupp led Pfizer's Michigan laboratories in pharmacokinetics, dynamics and metabolism, and chaired the Midwest Exploratory Development Management Team in Pfizer Global Research and Development. She began her career in 1987 at Bristol-Myers Squibb where she held positions of increasing responsibility in drug metabolism and pharmacokinetics. This experience led to her appointment as executive director, Drug Metabolism and Pharmacokinetics. Her last position with that company was as vice president, Chemical Manufacturing Controls (CMC), where she was responsible for global CMC regulatory submissions. Prior to joining Pfizer Animal Health, Dr. Knupp led Pfizer's Michigan laboratories in pharmacokinetics, dynamics and metabolism, and chaired the Midwest Exploratory Development Management Team in Pfizer Global Research and Development. She began her career in 1987 at Bristol-Myers Squibb where she held positions of increasing responsibility in drug metabolism and pharmacokinetics. This experience led to her appointment as executive director, Drug Metabolism and Pharmacokinetics. Her last position with that company was as vice president, Chemical Manufacturing Controls (CMC), where she was responsible for global CMC regulatory submissions.
Research Interest
Prior to joining Pfizer Animal Health, Dr. Knupp led Pfizer's Michigan laboratories in pharmacokinetics, dynamics and metabolism, and chaired the Midwest Exploratory Development Management Team in Pfizer Global Research and Development. She began her career in 1987 at Bristol-Myers Squibb where she held positions of increasing responsibility in drug metabolism and pharmacokinetics. This experience led to her appointment as executive director, Drug Metabolism and Pharmacokinetics. Her last position with that company was as vice president, Chemical Manufacturing Controls (CMC), where she was responsible for global CMC regulatory submissions.
